These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12354468)

  • 1. Epidemiology on trial--confessions of an expert witness.
    McPherson K
    Lancet; 2002 Sep; 360(9337):889-90. PubMed ID: 12354468
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology on trial.
    de Laat W; Raff WK
    Lancet; 2002 Nov; 360(9345):1611-2. PubMed ID: 12443645
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology on trial.
    Barton A
    Lancet; 2002 Nov; 360(9345):1612. PubMed ID: 12443647
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormonal contraception and venous thrombosis].
    Lidegaard Ø
    Ugeskr Laeger; 2013 May; 175(20):1401. PubMed ID: 23663393
    [No Abstract]   [Full Text] [Related]  

  • 5. Wyeth suppresses research on pill, programme claims.
    van Heteren G
    BMJ; 2001 Mar; 322(7286):571. PubMed ID: 11238142
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral contraceptives and venous thromboembolic events.
    Shulman LP; Goldzieher JW; Minkin MJ; Sulak PJ; Thorneycroft I
    J Reprod Med; 2003 Apr; 48(4):306-7. PubMed ID: 12747000
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal contraception and venous thromboembolic risk in midlife women.
    Lidegaard Ø
    Maturitas; 2013 Jan; 74(1):1-2. PubMed ID: 23098858
    [No Abstract]   [Full Text] [Related]  

  • 8. [Deep venous thrombosis in an adolescent taking oral contraceptives].
    de Tournemire R; Maugas AC
    Arch Pediatr; 2002 Aug; 9(8):873-4. PubMed ID: 12205799
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.
    Zakharova MY; Meyer RM; Brandy KR; Datta YH; Joseph MS; Schreiner PJ; Rao GH; Divani AA
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):323-31. PubMed ID: 20530058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diane-35 (cyproterone acetate): safety concerns.
    Wooltorton E
    CMAJ; 2003 Feb; 168(4):455-6. PubMed ID: 12591790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complications of hormonal contraception. 38th Congress of the "Zurich Discussion Group", April 2007].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2009; 49(1):39-44. PubMed ID: 19204401
    [No Abstract]   [Full Text] [Related]  

  • 13. UK high court dismisses risk of VTE in "pill" test case.
    Ashraf H
    Lancet; 2002 Aug; 360(9330):391. PubMed ID: 12241785
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
    Thromb Haemost; ; . PubMed ID: 23407778
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.